Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 38% ± 15% | |
type I pneumocyte | 11 studies | 43% ± 17% | |
astrocyte | 6 studies | 22% ± 4% | |
mesothelial cell | 6 studies | 26% ± 9% | |
enterocyte | 5 studies | 28% ± 6% | |
fibroblast | 5 studies | 20% ± 3% | |
glial cell | 4 studies | 46% ± 20% | |
podocyte | 3 studies | 62% ± 8% | |
Schwann cell | 3 studies | 54% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 24% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 4251.86 | 177 / 180 | 98% | 47.62 | 421 / 430 |
brain | 94% | 6591.34 | 2481 / 2642 | 99% | 39.11 | 697 / 705 |
pancreas | 100% | 4455.47 | 328 / 328 | 92% | 46.21 | 164 / 178 |
intestine | 99% | 8433.49 | 960 / 966 | 92% | 29.27 | 486 / 527 |
stomach | 100% | 7412.31 | 359 / 359 | 88% | 25.86 | 252 / 286 |
prostate | 100% | 6219.13 | 244 / 245 | 85% | 11.88 | 428 / 502 |
kidney | 100% | 11106.37 | 89 / 89 | 77% | 24.83 | 694 / 901 |
thymus | 98% | 4670.57 | 642 / 653 | 73% | 16.10 | 439 / 605 |
uterus | 99% | 7725.00 | 169 / 170 | 66% | 25.05 | 302 / 459 |
lung | 99% | 8665.02 | 575 / 578 | 59% | 15.77 | 679 / 1155 |
bladder | 95% | 3290.67 | 20 / 21 | 63% | 18.32 | 316 / 504 |
breast | 81% | 2723.18 | 373 / 459 | 68% | 23.50 | 762 / 1118 |
adrenal gland | 100% | 30275.75 | 258 / 258 | 47% | 26.91 | 107 / 230 |
esophagus | 75% | 5020.15 | 1085 / 1445 | 61% | 17.85 | 111 / 183 |
skin | 29% | 615.22 | 531 / 1809 | 79% | 68.72 | 374 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 47.59 | 1 / 1 |
blood vessel | 94% | 3564.82 | 1250 / 1335 | 0% | 0 | 0 / 0 |
heart | 86% | 3313.57 | 739 / 861 | 0% | 0 | 0 / 0 |
adipose | 81% | 3780.46 | 970 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 59% | 9.12 | 47 / 80 |
liver | 3% | 55.97 | 7 / 226 | 32% | 7.81 | 128 / 406 |
spleen | 19% | 378.81 | 46 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 3.06 | 8 / 45 |
muscle | 4% | 67.22 | 32 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0061643 | Biological process | chemorepulsion of axon |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0001755 | Biological process | neural crest cell migration |
GO_0007267 | Biological process | cell-cell signaling |
GO_0007411 | Biological process | axon guidance |
GO_0050919 | Biological process | negative chemotaxis |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005886 | Cellular component | plasma membrane |
GO_0045499 | Molecular function | chemorepellent activity |
GO_0030215 | Molecular function | semaphorin receptor binding |
Gene name | SEMA3B |
Protein name | Semaphorin-3B (Sema A(V)) (Semaphorin-V) (Sema V) SEMA3B protein Semaphorin 3B (cDNA FLJ55830, highly similar to Semaphorin-3B) Semaphorin 3B Semaphorin-3B |
Synonyms | SEMA5 SEMAA |
Description | FUNCTION: Inhibits axonal extension by providing local signals to specify territories inaccessible for growing axons. . |
Accessions | ENST00000418576.3 ENST00000611067.4 A0A087WZE0 A0A1S5UZH6 ENST00000456560.6 A0A0C4DGV8 ENST00000433753.4 [Q13214-2] Q6PI51 ENST00000621029.4 Q13214 ENST00000618865.4 [Q13214-1] ENST00000616701.5 [Q13214-1] B4DEK9 |